152 related articles for article (PubMed ID: 1329996)
1. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group.
Horn-Ross PL; Whittemore AS; Harris R; Itnyre J
Epidemiology; 1992 Nov; 3(6):490-5. PubMed ID: 1329996
[TBL] [Abstract][Full Text] [Related]
2. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
3. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
[TBL] [Abstract][Full Text] [Related]
4. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group.
John EM; Whittemore AS; Harris R; Itnyre J
J Natl Cancer Inst; 1993 Jan; 85(2):142-7. PubMed ID: 8418303
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
6. Intrauterine factors and risk of nonepithelial ovarian cancers.
Sieh W; Sundquist K; Sundquist J; Winkleby MA; Crump C
Gynecol Oncol; 2014 May; 133(2):293-7. PubMed ID: 24530563
[TBL] [Abstract][Full Text] [Related]
7. The reduction in risk of ovarian cancer associated with oral-contraceptive use.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
N Engl J Med; 1987 Mar; 316(11):650-5. PubMed ID: 3821795
[TBL] [Abstract][Full Text] [Related]
8. Hormonal and reproductive factors and the risk of ovarian cancer.
Koushik A; Grundy A; Abrahamowicz M; Arseneau J; Gilbert L; Gotlieb WH; Lacaille J; Mes-Masson AM; Parent MÉ; Provencher DM; Richardson L; Siemiatycki J
Cancer Causes Control; 2017 May; 28(5):393-403. PubMed ID: 28102526
[TBL] [Abstract][Full Text] [Related]
9. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
Risch HA; Marrett LD; Jain M; Howe GR
Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
[TBL] [Abstract][Full Text] [Related]
10. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
Franceschi S; Parazzini F; Negri E; Booth M; La Vecchia C; Beral V; Tzonou A; Trichopoulos D
Int J Cancer; 1991 Aug; 49(1):61-5. PubMed ID: 1874572
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for epithelial ovarian cancer in Beijing, China.
Chen Y; Wu PC; Lang JH; Ge WJ; Hartge P; Brinton LA
Int J Epidemiol; 1992 Feb; 21(1):23-9. PubMed ID: 1544753
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking and the risk of epithelial ovarian cancer.
Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the association of oral contraceptives and ovarian cancer.
Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
[TBL] [Abstract][Full Text] [Related]
14. Events of reproductive life and the incidence of epithelial ovarian cancer.
Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer.
Gwinn ML; Lee NC; Rhodes PH; Layde PM; Rubin GL
J Clin Epidemiol; 1990; 43(6):559-68. PubMed ID: 2348208
[TBL] [Abstract][Full Text] [Related]
16. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
[TBL] [Abstract][Full Text] [Related]
17. The risk of epithelial ovarian cancer in short-term users of oral contraceptives.
Gross TP; Schlesselman JJ; Stadel BV; Yu W; Lee NC
Am J Epidemiol; 1992 Jul; 136(1):46-53. PubMed ID: 1415131
[TBL] [Abstract][Full Text] [Related]
18. Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.
Gnagy S; Ming EE; Devesa SS; Hartge P; Whittemore AS
Epidemiology; 2000 Mar; 11(2):102-5. PubMed ID: 11021604
[TBL] [Abstract][Full Text] [Related]
19. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676
[TBL] [Abstract][Full Text] [Related]
20. Population-based case-control study of ovarian cancer in Shanghai.
Shu XO; Brinton LA; Gao YT; Yuan JM
Cancer Res; 1989 Jul; 49(13):3670-4. PubMed ID: 2731180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
